Rejuvenate Bio today announced a partnership with a leading animal health company for the development and commercialization of its novel gene therapy technology for the treatment of canine osteoarthritis (OA), a complex chronic disease that affects dogs’ mobility and overall quality of life.

The prevalence of OA in dogs is alarmingly high, affecting over 40% of our beloved canine companions according to recent studies. With an estimated 86 million dogs in households across the United States, the impact of this condition is widespread, yet often underestimated and inadequately addressed.

The consequences of untreated OA extend far beyond physical discomfort, often leading to a stark decline in mobility and overall well-being. Tragically, OA ranks among the leading causes of euthanasia in dogs, highlighting the urgent need for effective treatment options that can alleviate suffering and prolong life.

Enter Rejuvenate Bio's groundbreaking gene therapy technology, which offers a promising alternative to traditional treatment approaches. Unlike conventional therapies that may require frequent administration and provide only temporary relief, this innovative one-dose injection targets the underlying causes of OA, potentially offering long-term benefits.

Dan Oliver, CEO & Co-Founder of Rejuvenate Bio, underscores the significance of this partnership and its validation of their pioneering approach to tackling age-related diseases. He emphasizes the importance of ensuring that this transformative therapy reaches those dogs in dire need, affirming its potential to not only improve joint health but also to enhance the overall quality of life for animals and eventually for humans grappling with OA.

The collaboration with a leading animal health company marks a significant milestone for Rejuvenate Bio, building upon previous successes in the realm of gene therapy development. With this partnership, the company is poised to usher in a new era of treatment options for OA, offering hope and relief to countless dogs and their devoted owners.

As research and development efforts continue to progress, the future looks brighter than ever for dogs battling OA. With Rejuvenate Bio's innovative gene therapy leading the charge, a world where arthritis pain is a thing of the past for our furry friends may soon become a reality.